ClinTex

ClinTex

Created using Figma
Created using Figma
ClinTex deliver intuitive blockchain-based self service analytic solutions to the pharmaceutical industry.
  • Market
    Pair
    Price
    Volume 24H
    24H (price)
    24H (volume)
  • XT.COM
    CTI/USDT 9 days ago
    $ 0.0146
    $ 41.75
    -
    -
  • KuCoin
    CTI/USDT 7 months ago
    $ 0.0636
    $ 262.764 K
    -1.13%
    -10.62%
  • KuCoin
    CTI/ETH 7 months ago
    $ 0.0626
    $ 93.019 K
    -2.51%
    -10.46%
PRE ICO
To be announced
Token Details
Ticker
CTI
Accepted Currencies
ETH, BTC
Company Details
Registered Country
Malta
Additional Details
KYC
Yes
Categories
Platform, Health, Other

About ClinTex

ClinTex are a solution provider to the pharmaceutical industry, and the team behind CTi – Clinical Trials Intelligence:

A new type of software platform aimed at transforming the medicine development industry through the application of predictive analytics, machine learning, and the novel use of blockchain technology and smart contracts in clinical trials.

Our mission is to bring down the cost of medicine and improve the speed to market of new medicines for the people who need them, through vastly reducing development costs for the global pharmaceutical industry.

ClinTex Roadmap

  • Q2 2018

  • CTi Data Model Design;
    CTi-OEM Prototype Development.
  • Q3 2018

  • Pre Sale TGE;
    Public TGE.
  • Q4 2018

  • CTi GUI Development (with Integrated CLX Wallet);
    Blockchain Verification of CTi Pre-Processing Data.
  • Q1 2019

  • Blockchain Verification of CTi Pre-Processing Data;
    CTi-OEM DEvelopment.
  • Read More
  • Q2 2019

  • CTi-PDA Development.
  • Q3 2019

  • CTi-PRR Development;
    Migration on-chain of CTiClinical Data Statistical Summaries.
  • Q4 2019

  • CTi-RBM Development;
    CTi-CDV Development.
  • Q1 2020

  • Cti-VMM Development.
  • Q2 2020

  • CTi-SIM Development.
  • Q3-Q4 2020

  • Migration on-chain of the CTi Data Model and CTi Processing Engine,

Activity

Followers:
5 745
HIGH
Tweets:
546
VERY HIGH
30 Days Growth:
-6
Members:
18
VERY LOW
30 Days Growth:
-1

ClinTex Team

Verified 14%

Attention. There is a risk that unverified members are not actually members of the team

Ethan Diamant
Director of Clinical Data Services
unverified
Andre Byrne
Chief Marketing Officer
unverified
Ed Burke
Senior Developer
unverified
Shilpy Goyal
Data Analytics Developer
unverified
Neill Barron
Director of Clinical Data Services
unverified
Brendan O’Mainnin
Director of Operations
verified
John Mccabe
Head of Legal & Regulatory
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Sean Comiskey
Technology Engineering Advisor
unverified

ClinTex Interviews

Brendan O’Mainnin
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
CTi is the first blockchain enterprise solution that will tackle a critical and current problem in the world with regard to the high cost of medical treatments as a result of clinical trial expenditure.
As a team member, сan you tell us about your role in the ICO project?
I oversee all day-to-day administrative and operational functions of the business, the management of all marketing initiatives and the design of operational strategy for ClinTex.
What do you think about idea?
Pharmaceutical companies can now gain deep insight into the operational and clinical aspects of their trials without the necessity of major investment into backend technical infrastructure or data science expertise
$ 0.0104
2.83%
Crypto Stats
Daily, %:
2.83%
Weekly, %:
-13.79%
Monthly, %:
-53.05%
Market Info
Market Cap:
$ 868.576 K
Volume 24h:
$ 365.853 K
Circ. Supply:
83.288 M CTI
Ticker:
CTI
ICO profit
X 0.1041
ICO Price~$0.1000

ClinTex Reviews

icoexaminer.com
ICO review website

There is enough material to suggest that ClinTex is aiming to address a real need within the clinical trial field. Tokenomics for the project are straightforward with minimal bonuses applicable and a clear team vesting period. The acceptance of Binance coin in the ICO adds another level of interest and, although no partnership is stated or implied, investors may feel it increases the possibility of a future listing opportunity with the exchange.

Maybe most importantly, an able team is backed by experienced advisors and together they have shown the foresight to partner with useful allies within the blockchain arena and realm of medical services.

The downside column is much shorter but it should be noted that there is currently no working product and the roadmap suggests that some of the infrastructure will not be fully available until well into 2020 which could hamper uptake of the platform.

The whitepaper states that one of the reasons ClinTex ClinTex has partnered with Intellimed is that they will “…deploy the CTi platform in academic clinical research settings.”

This suggests that a firm footing for the initial launch of the platform has been established so it is the forward momentum of ClinTex, that includes expected on-boarding of other pharmaceutical companies in mid-2019, that contributors to the ICO will need to judge.

Given that they have first mover advantage in this particular specialised arena, the fundamentals appear to outweigh the minor concern and marks ClinTex as an ICO worthy of serious consideration.

Read More
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.